A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C

NCT01591460 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: boceprevir
DRUG: peginterferon alfa-2a [Pegasys]
DRUG: peginterferon alfa-2a [Pegasys]
DRUG: ribavirin (Copegus]
DRUG: ribavirin (Copegus]

Sponsor

Hoffmann-La Roche